Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7171 AL 7185

Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation

Kamal MA, Priyamvada S, Anbazhagan AN, Jabir NR, Tabrez S, Greig NH.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):338-46. doi: 10.2174/18715273113126660137.

Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease

Song J, Park KA, Lee WT, Lee JE.

Int J Mol Sci. 2014 Jan 29;15(2):2119-29. doi: 10.3390/ijms15022119.

Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target

Wilhelmus MM, de Jager M, Bakker EN, Drukarch B.

J Alzheimers Dis. 2014;42 Suppl 3:S289-303. doi: 10.3233/JAD-132492.

Activation and regulation of caspase-6 and its role in neurodegenerative diseases

Wang XJ, Cao Q, Zhang Y, Su XD.

Annu Rev Pharmacol Toxicol. 2015;55:553-72. doi: 10.1146/annurev-pharmtox-010814-124414. Epub 2014 Oct 17.

Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin

Maiti P, Manna J, Veleri S, Frautschy S.

Biomed Res Int. 2014;2014:495091. doi: 10.1155/2014/495091. Epub 2014 Oct 19.

A network approach to clinical intervention in neurodegenerative diseases

Santiago JA, Potashkin JA.

Trends Mol Med. 2014 Dec;20(12):694-703. doi: 10.1016/j.molmed.2014.10.002. Epub 2014 Oct 30.

HtrA protease family as therapeutic targets

Skorko-Glonek J, Zurawa-Janicka D, Koper T, Jarzab M, Figaj D, Glaza P, Lipinska B.

Curr Pharm Des. 2013;19(6):977-1009. doi: 10.2174/1381612811319060003.

Mitochondria as a pharmacological target: magnum overview

Olszewska A, Szewczyk A.

IUBMB Life. 2013 Mar;65(3):273-81. doi: 10.1002/iub.1147.

Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence

Calderón-Garcidueñas L, Franco-Lira M, Mora-Tiscareño A, Medina-Cortina H, Torres-Jardón R, Kavanaugh M.

Biomed Res Int. 2013;2013:161687. doi: 10.1155/2013/161687. Epub 2013 Feb 7.

Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease

Dos Santos VV, Rodrigues AL, De Lima TC, de Barioglio SR, Raisman-Vozari R, Prediger RD.

Curr Pharm Des. 2013;19(38):6773-90. doi: 10.2174/13816128113199990411.

Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage

Reddy PH.

Biochim Biophys Acta. 2013 Dec;1832(12):1913-21. doi: 10.1016/j.bbadis.2013.06.012. Epub 2013 Jun 28.

Molecular biomarkers of neurodegeneration

Höglund K, Salter H.

Expert Rev Mol Diagn. 2013 Nov;13(8):845-61. doi: 10.1586/14737159.2013.850033.

Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration

Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Plácido A, Santos MS, Oliveira CR, Moreira PI.

Biochim Biophys Acta. 2013 Apr;1832(4):527-41. doi: 10.1016/j.bbadis.2013.01.008. Epub 2013 Jan 11.

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G.

Transl Psychiatry. 2013 Dec 3;3(12):e332. doi: 10.1038/tp.2013.97.

Cervical dystonia in an Alzheimer's disease patient treated with donepezil

Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.

Acta Neurol Belg. 2013 Sep;113(3):363-4. doi: 10.1007/s13760-012-0143-9. Epub 2012 Oct 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias